Show simple item record

dc.contributor.authorde Hollanda, Ana
dc.contributor.authorLecube Torelló, Albert
dc.contributor.authorRubio, Miguel Ángel
dc.contributor.authorSánchez Peña, Enric
dc.contributor.authorVilarrasa, Núria
dc.contributor.authorGregorio Oliva, José
dc.contributor.authorFernández-Soto, María Luisa
dc.contributor.authorSalas-Salvadó, Jordi
dc.contributor.authorBallesteros-Pomar, María D.
dc.contributor.authorCiudin, Andreea
dc.contributor.authorTorres, Ferran
dc.contributor.authorVidal, Concepción
dc.contributor.authorMorales, María José
dc.contributor.authorValdés, Sergio
dc.contributor.authorPellitero, Silvia
dc.contributor.authorMiñambres, Inka
dc.contributor.authorMasmiquel, Lluís
dc.contributor.authorGoday, Albert
dc.contributor.authorSuarez, Lorena
dc.contributor.authorFlores, Liliam
dc.contributor.authorBueno Díez, Marta
dc.contributor.authorCaixàs, Assumpta
dc.contributor.authorBretón, Irene
dc.contributor.authorCámara, Rosa
dc.contributor.authorOlbeyra, Romina
dc.contributor.authorPenso, Rona
dc.contributor.authorde la Cruz, María José
dc.contributor.authorSimó-Servat, Andreu
dc.contributor.authorPereyra-García, Francisca María
dc.contributor.authorLópez-Mezquita, Elena Teresa
dc.contributor.authorGils, Anna
dc.contributor.authorFidilio, Enzamaria
dc.contributor.authorBandrés, Orosia
dc.contributor.authorMartínez, Ángel
dc.contributor.authorAbuín, Jose
dc.contributor.authorMarques-Pamies, Montserrat
dc.contributor.authorTuneu, Laura
dc.contributor.authorArteaga, Magdalena
dc.contributor.authorCastañer, Olga
dc.contributor.authorGoñi, Fernando
dc.contributor.authorArrizabalaga, Cristina
dc.contributor.authorBotana, Manuel Antonio
dc.contributor.authorCalañas, Alfonso
dc.date.accessioned2020-10-02T08:28:57Z
dc.date.available2020-10-02T08:28:57Z
dc.date.issued2020
dc.identifier.issn2077-0383
dc.identifier.urihttp://hdl.handle.net/10459.1/69595
dc.description.abstractAlmost one third of patients do not achieve type 2 diabetes remission after bariatric surgery or are unable to sustain this effect long term. Our objective was to delve further into the dynamic responses of diabetes after bariatric surgery and to evaluate the “time-within-remission range” as a variable of metabolic control. A descriptive cohort study was done using a computerised multicentre and multidisciplinary registry. All data were adjusted by propensity score. A total of 1186 subjects with a follow-up of 4.5 ± 2.5 years were included. Type of surgery, diabetes remission, recurrence of diabetes, “time-within-remission range” and key predictors of diabetes outcomes were assessed. All patients (70% women, 51.4 ± 9.2 years old, body mass index (BMI) 46.3 ± 6.9 kg/m2 ) underwent primary bariatric procedures. “Time-within-remission range” were 83.3% (33.3–91.6) after gastric bypass, 68.7% (7.1–87.5) after sleeve gastrectomy and 90% (83.3–92.8) after malabsorptive techniques (p < 0.001 for all). Duration of diabetes, baseline HbA1c and insulin treatment were significantly negatively correlated with the “time-within-remission range”. The association of bariatric techniques with “time-within-remission range”, using gastric bypass as a reference, were: odds ratio (OR) 3.70 (2.34–5.84), p < 0.001 for malabsorptive techniques and OR 0.55 (0.40–0.75), p < 0.001 for sleeve gastrectomy. Characteristics of type 2 diabetes powerfully influence the outcomes of bariatric surgery. The “time-within-remission range” unveils a superiority of gastric bypass compared to sleeve gastrectomyca_ES
dc.description.sponsorshipThis study was supported by the Spanish Society of Endocrinology and Nutrition (SEEN). The RICIBA and RICIBA-DM are property of the Spanish Society of Endocrinology and Nutrition (SEEN). J.S.S. gratefully acknowledges the financial support by ICREA under the ICREA Academia programme.ca_ES
dc.language.isoengca_ES
dc.publisherMDPIca_ES
dc.relation.isformatofhttps://doi.org/10.3390/jcm9041070ca_ES
dc.relation.ispartofJournal of Clinical Medicine, 2020, vol. 9, núm. 4, p. 1070ca_ES
dc.rightscc-by (c) de Hollanda, Ana et al., 2020ca_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectBariatric surgeryca_ES
dc.subjectTime-within-remission rangeca_ES
dc.subjectType 2 diabetesca_ES
dc.subjectMetabolic controlca_ES
dc.titleNew Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The “Time-Within-Remission Range”ca_ES
dc.typeinfo:eu-repo/semantics/articleca_ES
dc.identifier.idgrec030040
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_ES
dc.identifier.doihttps://doi.org/10.3390/jcm9041070


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

cc-by (c) de Hollanda, Ana et al., 2020
Except where otherwise noted, this item's license is described as cc-by (c) de Hollanda, Ana et al., 2020